Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES 简体中文 中文 हिन्दी HI
Sign Up
Log in
CorMedix Inc banner

CorMedix Inc
SWB:19KA

Watchlist Manager
CorMedix Inc Logo
CorMedix Inc
SWB:19KA
Watchlist
Price: 6.868 EUR 12.59% Market Closed
Market Cap: €377.5m
Write Note Create Alert

Intrinsic Value

Is 19KA undervalued or overvalued?

See the intrinsic value estimate for CorMedix Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

19KA Intrinsic Value
LOCKED
Unlock
Today vs. history

19KA looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with 19KA’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor 19KA
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Margin of Safety 20% Locked
Current Price €6.87
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to 19KA

Fundamental Analysis

What CorMedix Does

Pharmaceuticals Health Care

CorMedix is a biopharmaceutical company focused on reducing infections tied to medical devices. Its main product is a catheter lock solution used inside central venous catheters to help prevent serious bloodstream infections, especially in patients who rely on long-term vascular access such as hemodialysis patients. In simple terms, the company sells a drug product designed to sit in the catheter when it is not in use and lower the chance that bacteria will grow there.

Headquarters
United States of America US
Employees
191
IPO date
Mar 25, 2010
Read the full company overview
View Company Overview

CorMedix has a narrow economic moat

No Moat Narrow Wide

CorMedix Inc has a narrow economic moat, offering limited protection against competitors and some ability to sustain profitability.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
CorMedix Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

CRMD Insider Trading
Buy and sell transactions by insiders

Continue 19KA Research

Summary
19KA intrinsic value, competitors valuation, and company profile.
DCF Valuation
19KA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
19KA stock valuation using valuation multiples.
Wall St Estimates
19KA price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financial Statements
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
19KA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financial Statements
Discount Rate
Other CorMedix Inc listings:
NASDAQ • USD
CRMD
 F • EUR
19KA
Discover More
What is the Intrinsic Value of one 19KA stock?

The intrinsic value for CorMedix Inc (19KA) under the Base Case is hidden EUR.

Is 19KA stock undervalued or overvalued?

Compared with the current market price of 6.868 EUR, the stock appears hidden.

Back to Top
ALPHA SPREAD
Follow us
Join 363,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.